Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety Of CC-5013 vs. Placebo In Subjects with Metastatic Malignant Melanoma Whose Disease Has Progressed On Treatment With DTIC, IL-2 Or IFN-a ...

Short title	Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Compare the Efficacy and Safety Of CC-5013 vs. Placebo In Subjects with Metastatic Malignant Melanoma Whose Disease Has Progressed On Treatment With DTIC, IL-2 Or IFN-a ...
Status	Finished
Effective start/end date	1/01/03 → 31/12/03

Project Details